The Department of Veterans Affairs (VA) has awarded a series of contracts and agreements to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders, to provide the medication WAKIX (pitolisant).
Harmony Biosciences holds a $5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center and a $259,000 multiple award indefinite-delivery indefinite-quantity (IDIQ) contract with the VA Veterans Health Administration to supply WAKIX and other pharmaceutical products against the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). These vehicles allow the VA to streamline procurement of WAKIX, which is used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients, for VA medical facilities nationwide. In addition, Harmony Biosciences has received numerous firm fixed-price delivery orders valued from $5,000 to over $700,000 against these contract vehicles to provide WAKIX tablets to VA locations across the country. No set-aside provisions have been applied to these pharmaceutical procurements.
Generated 11/19/24, 9:05 AM